Your email address:

Powered by FeedBlitz

Wendy crop  compress  40

My Mission

Helping Others through the Synergy of Science and Caring
How this blog supports my mission


« Vacation From Late Stage Cancer | Main | Anguished Debate on Witholding Rx for the Control Arm »

September 22, 2010


Feed You can follow this conversation by subscribing to the comment feed for this post.

sue c

I think one of the problems with this sort of research has been "individuality." You might have a new therapy where 33% get better, 33% no change and 33% get worse. It will not show efficacy, yet the 33% who might do better on this never get a chance. We need to be able to identify who gets better on it and why and make it available for these groups, regardless of the wider population who it might not help.


The article was discussed at the LRF conference this weekend in San Francisco. I haven't yet finished my evaluation form. Would you mind if I suggest you as a speaker?

The comments to this entry are closed.

Blog powered by Typepad